Literature DB >> 27600181

Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.

Maxwell D Anderegg1, Tyler H Gums1, Liz Uribe1, Christopher S Coffey1, Paul A James1, Barry L Carter2.   

Abstract

Physician-pharmacist collaboration improves blood pressure, but there is little information on whether this model can reduce the gap in healthcare disparities. This trial involved 32 medical offices in 15 states. A clinical pharmacist was embedded within each office and made recommendations to physicians and patients in intervention offices. The purpose of the present analysis was to evaluate whether the pharmacist intervention could reduce healthcare disparities by improving blood pressure in high-risk racial and socioeconomic subjects compared with the control group. The analyses in minority subjects were prespecified secondary analyses, but all other comparisons were secondary, post hoc analyses. The 9-month visit was completed by 539 patients: 345 received the intervention, and 194 were in the control group. Following the intervention, mean systolic blood pressure was found to be 7.3 mm Hg (95% confidence interval 2.4, 12.3) lower in subjects from racial minority groups who received the intervention compared with the control group (P=0.0042). Subjects with ≤12 years of education in the intervention group had a systolic blood pressure 8.1 mm Hg (95% confidence interval 3.2, 13.1) lower than the control group with lower education (P=0.0001). Similar reductions in blood pressure occurred in patients with low incomes, those receiving Medicaid, or those without insurance. This study demonstrated that a pharmacist intervention reduced racial and socioeconomic disparities in the treatment of blood pressure. Although disparities in blood pressure were reduced by the intervention, there were still nonsignificant gaps in mean systolic blood pressure when compared with intervention subjects not at risk. CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov. Unique identifier: NCT00935077.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; healthcare disparities; minority populations; pharmacist intervention; team care

Mesh:

Substances:

Year:  2016        PMID: 27600181      PMCID: PMC5063695          DOI: 10.1161/HYPERTENSIONAHA.116.08043

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  33 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Nurse-led disease management for hypertension control in a diverse urban community: a randomized trial.

Authors:  Paul L Hebert; Jane E Sisk; Leah Tuzzio; Jodi M Casabianca; Velvie A Pogue; Jason J Wang; Yingchun Chen; Christine Cowles; Mary Ann McLaughlin
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

3.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

4.  Forward: CDC Health Disparities and Inequalities Report - United States, 2011.

Authors:  Thomas R Frieden
Journal:  MMWR Suppl       Date:  2011-01-14

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

Review 7.  Primary Care Physician-Pharmacist Collaborative Care Model: Strategies for Implementation.

Authors:  Barry L Carter
Journal:  Pharmacotherapy       Date:  2016-04-06       Impact factor: 4.705

8.  Vital signs: awareness and treatment of uncontrolled hypertension among adults--United States, 2003-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-09-07       Impact factor: 17.586

9.  Racial differences in two self-management hypertension interventions.

Authors:  Hayden B Bosworth; Maren K Olsen; Janet M Grubber; Benjamin J Powers; Eugene Z Oddone
Journal:  Am J Med       Date:  2011-05       Impact factor: 4.965

10.  A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; George R Bergus; Jeffrey D Dawson; Karen B Farris; William R Doucette; Elizabeth A Chrischilles; Arthur J Hartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

View more
  13 in total

1.  The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research.

Authors:  George A Mensah; Catherine M Stoney; Michelle M Freemer; Sharon Smith; Michael M Engelgau; W Keith Hoots; James P Kiley; David C Goff
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

2.  A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.

Authors:  Ronald G Victor; Kathleen Lynch; Ning Li; Ciantel Blyler; Eric Muhammad; Joel Handler; Jeffrey Brettler; Mohamad Rashid; Brent Hsu; Davontae Foxx-Drew; Norma Moy; Anthony E Reid; Robert M Elashoff
Journal:  N Engl J Med       Date:  2018-03-12       Impact factor: 91.245

3.  Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.

Authors:  Maxwell D Anderegg; Tyler H Gums; Liz Uribe; Eric J MacLaughlin; James Hoehns; Oralia V Bazaldua; Timothy J Ives; David L Hahn; Christopher S Coffey; Barry L Carter
Journal:  Pharmacotherapy       Date:  2018-02-23       Impact factor: 4.705

Review 4.  Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature.

Authors:  Korey A Kennelty; Linnea A Polgreen; Barry L Carter
Journal:  Curr Hypertens Rep       Date:  2018-01-18       Impact factor: 5.369

5.  Collaborative care model for hypertension.

Authors:  Barry L Carter
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-13       Impact factor: 3.738

6.  Pharmacist-physician collaborative care model and time to goal blood pressure in the uninsured population.

Authors:  Dave L Dixon; Evan M Sisson; Eric D Parod; Benjamin W Van Tassell; Pramit A Nadpara; Daniel Carl; Alan W Dow
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-13       Impact factor: 3.738

Review 7.  Pharmacist services for non-hospitalised patients.

Authors:  Mícheál de Barra; Claire L Scott; Neil W Scott; Marie Johnston; Marijn de Bruin; Nancy Nkansah; Christine M Bond; Catriona I Matheson; Pamela Rackow; A Jess Williams; Margaret C Watson
Journal:  Cochrane Database Syst Rev       Date:  2018-09-04

Review 8.  Avoiding Pitfalls With Implementation of Randomized Controlled Multicenter Trials: Strategies to Achieve Milestones.

Authors:  Barry L Carter; Gail Ardery
Journal:  J Am Heart Assoc       Date:  2016-12-19       Impact factor: 5.501

9.  A community-wide quality improvement initiative to improve hypertension control and reduce disparities.

Authors:  Robert J Fortuna; Thomas A Rocco; Jeffrey Freeman; Mathew Devine; John Bisognano; Geoffrey C Williams; Angela Nagel; Howard Beckman
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-01-04       Impact factor: 3.738

Review 10.  Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence.

Authors:  Keith C Ferdinand; Kapil Yadav; Samar A Nasser; Helene D Clayton-Jeter; John Lewin; Dennis R Cryer; Fortunato Fred Senatore
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-08-30       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.